Table 7. Comparative ADMET profile of the test ligands and the control.
| Blood-Brain Barrier | Human Intestinal Absorption | AMES Toxicity | Carcinogenicity | LD50 in rats | |
| CP 690,550 (Tofacitinib) | 0.9568 | 0.9897 | 0.5492 | Non- carcinogenic | 2.7249 |
| Cmpd 4 | 0.9806 | 0.9958 | 0.584 | Non- carcinogenic | 2.5278 |
| PubChem CID 76749591 | 0.9598 | 0.9956 | 0.5407 | Non- carcinogenic | 2.7101 |
| PubChem CID 123462422 | 0.9631 | 0.9973 | 0.5608 | Non- carcinogenic | 2.7365 |